Bayer AG News

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The Stoxx Europe 600 Index lost 0.9 percent to 261.24. The Stoxx 50 Index fell 0.9 percent to 2,468.05. The Euro Stoxx 50 Index, a benchmark measure for nations using the euro, declined 1.7 percent to 2,480.76. Alstom SA : The French company and Cofely Besix Facility Management said they won a 13-year contract worth 120 million euros from Dubai's ... (more)

Bayer and Almirall to co-promote anticoagulant Rivaroxaban in Spain Rivaroxaban an innovative oral anticoagulant developed by Bayer, is a new option for stroke prevention in atrial fibrillation recently approved in Europe and the United States Atrial fibrillation is the most common sustained cardiac rhythm disorder and affects more than 6 million ... (more)

Germany's largest drugmaker, Bayer AG, expects to obtain approval within two years from China to expand the uses for its anti-clotting drug Xarelto to include stroke prevention.

Bayer CropScience , one of the world's top innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits, has announced that Dr.

Marijn Dekkers, head of German drug-and-chemicals giant Bayer AG, says consumers don't give pharmaceuticals enough credit.

The Jasper-based company reported net income of $3.2 million for the quarter ending Dec.

The 2012 interns selected to participate in this prestigious program will spend five weeks of the eight-week program at a local hemophilia organization.

And the expansion project received a financial boost from the Coon Rapids City Council and Coon Rapids Economic Development Authority in the form of grants totaling $340,000. The project approved by the city included renewing the lease at its current 50,000 square-foot building on Evergreen Boulevard and upgrading its equipment there as well as ... (more)

Bayer HealthCare, LLC today announced that the U.S. Food and Drug Administration agreed that Bayer can proceed with its expanded access program to provide the investigational drug radium-223 chloride to patients diagnosed with castration-resistant prostate cancer /hormone-refractory prostate cancer with symptomatic bone metastases.

A string of successes against advanced prostate cancer is offering men and their doctors new weapons to transform treatment of the lethal disease.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia German pharmaceutical company Bayer AG said Friday it got approval for use of Gadovist 1.0 in children aged two to six years in the Europe Union.

U.S. regulators approved Pfizer Inc.'s Inlyta drug for advanced kidney cancer Friday, the latest of several drugs to be approved for the disease in recent years.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia International pharmaceutical giant Bayer is planning to boost its investment in Australia and create nearly 1,000 jobs.

During International Green Week 2012 in Berlin, Germany, Joachim Schneider, Ph.D., senior vice president growth and strategy for Bayer CropScience, affirmed the company's commitment to addressing the challenges posed by population growth, the growing demand for food, feed and renewable raw materials, limited natural resources and climate change.

The following companies' shares may have unusual moves in European trading. All prices are from the previous close.

Bayer CropScience announced today that it has filed a patent infringement lawsuit in the United States District Court for the Eastern District of Virginia against Dow AgroSciences based upon DAS's unauthorized use of Bayer patents related to glufosinate-tolerance technology .

The company is focused on the development and manufacture of raw materials for coatings, adhesives and sealants.

The lawsuit asserts infringement of four Bayer patents and follows two previous claims involving seven Bayer glyphosate-tolerance technology patents and Bayer's 2,4-D herbicide tolerance patent.

Bayer AG was downgraded by research analysts at Nomura from a "buy" rating to a "neutral" rating in a report issued on Friday.